These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 5398002)
1. [Effect of antibiotic therapy on the course of homologous disease in mice-hybrids F 1]. Fedosov EA; Shevelev AS Biull Eksp Biol Med; 1969 Jun; 68(7):71-3. PubMed ID: 5398002 [No Abstract] [Full Text] [Related]
2. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease. Levi-Schaffer F; Goldenhersh MA; Segal V; Nagler A Bone Marrow Transplant; 1997 Apr; 19(8):823-8. PubMed ID: 9134176 [TBL] [Abstract][Full Text] [Related]
3. Reversal of post-thymectomy wasting disease in mice by multiple thymus grafts. Stutman O; Yunis EJ; Martinez C; Good RA J Immunol; 1967 Jan; 98(1):79-87. PubMed ID: 6018772 [No Abstract] [Full Text] [Related]
5. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice]. Li Y; Guo K; Chen Y; Song Z; Li J; Deng L Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044 [TBL] [Abstract][Full Text] [Related]
6. A two-phase pathogenesis of graft-versus-host disease in mice. van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710 [TBL] [Abstract][Full Text] [Related]
7. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation]. Du B; Li D; Xu K Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):403-7. PubMed ID: 11718089 [TBL] [Abstract][Full Text] [Related]
8. [Xenogeneic graft-versus-host disease]. Wang KJ; Li YP; Yang YR Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 May; 14(3):181-5. PubMed ID: 12080859 [TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation. Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715 [TBL] [Abstract][Full Text] [Related]
10. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation]. Ran HH; Pan KL; Zhang R; Wang YF Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403 [TBL] [Abstract][Full Text] [Related]
13. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia. Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959 [TBL] [Abstract][Full Text] [Related]
14. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice. Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770 [TBL] [Abstract][Full Text] [Related]
15. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Ilan Y; Ohana M; Pappo O; Margalit M; Lalazar G; Engelhardt D; Rabbani E; Nagler A Transplantation; 2007 Feb; 83(4):458-67. PubMed ID: 17318079 [TBL] [Abstract][Full Text] [Related]
16. Effect of sublethal total body irradiation on acute graft-versus-host disease and graft-versus-leukemia effect in SCID mice. Sakai R; Maruta A; Yanoma S; Shimizu A; Harada M; Nakamura Y; Kodama F; Okubo T Bone Marrow Transplant; 1997 Aug; 20(3):183-9. PubMed ID: 9257885 [TBL] [Abstract][Full Text] [Related]
17. The oxidative status of blood cells in a murine model of graft-versus-host disease. Amer J; Weiss L; Reich S; Shapira MY; Slavin S; Fibach E Ann Hematol; 2007 Oct; 86(10):753-8. PubMed ID: 17653715 [TBL] [Abstract][Full Text] [Related]